Erasca (ERAS) Inks Deal With Pfizer for Colorectal Cancer Study Posted byZacks Equity Research September 9, 2021 Leave a comment on Erasca (ERAS) Inks Deal With Pfizer for Colorectal Cancer Study Erasca (ERAS) signs an agreement with Pfizer for a clinical study, which will evaluate ERAS-007 in combination with encorafenib and cetuximab for BRAF…